BLANCHETTE SARAH F,FITZGERALD JONATHAN BASIL,GADDY DANIEL F,HENDRIKS BART S,KALRA ASHISH,LEE HELEN,BAYEVER ELIEL
申请号：
IN201817006671
公开号：
IN201817006671A
申请日:
2018.02.21
申请国别(地区):
IN
年份:
2018
代理人:
摘要：
Combination therapy regimens including liposomal irinotecan oxaliplatin and 5 fluorouracil are useful in the treatment of pancreatic cancer including treatment of patients diagnosed with previously untreated metastatic adenocarcinoma of the pancreas. The combination therapy can include the administration of liposomal irinotecan oxaliplatin leucovorin and 5 fluorouracil once every two weeks.
